Running a huge company certainly isn’t easy, especially when you have to be the face of the business. Because if you happen to make a mistake, you might not ever live it down. Netizens have been ...

Join Pete, a blind man, as he takes on the challenge of shopping for a Super Bowl party without relying on delivery services.

A mid-day audit covering the three railway lines of the city found that the six-inch unseen bolt that holds the doors of ...

For Kentucky fans, there were red flags all over the floor at Madison Square Garden tonight. From the Cats’ lack of defense to puzzling shot selection, Mark Pope’s worried look walking into Madison ...

“Imagine calling self-acceptance toxic. Couldn’t be me,” the model and body activist said Tess Holiday/TikTok Tess Holliday revived her "#effyourbeautystandards" movement, 13 years after creating it, ...

Tess Holliday revived her "#effyourbeautystandards" movement, 13 years after creating it, to promote self-acceptance and body positivity The model shared a TikTok video in a neon green bikini, ...

Tess Holliday is bringing back her “eff your beauty standards” movement. On Friday, Feb. 20, the model and body activist, 40, posted a video on TikTok and was all smiles as she posed and showed off ...

Novo Nordisk NOVO.B6.03%increase; green up pointing triangle shares fell 16% after the Danish drugmaker said its next-generation obesity treatment failed to outperform Eli Lilly’s Zepbound in a ...

Novo's drug, CagriSema, didn't achieve its key goal of demonstrating non-inferiority on weight loss when compared to Eli Lilly's rival drug tirzepatide. The stock plummeted on Monday, hitting its ...

Novo Nordisk shares fell sharply after the Danish drugmaker said its CagriSema experimental obesity treatment failed to beat the weight loss delivered by Eli Lilly's Zepbound in a head-to-head study.